Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

Clinical trial NCT06846541 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06846541
Sponsor: Alumis Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Plaque Psoriasis Psoriasis (PsO)Psoriasis Moderate Psoriasis Severe Psoriasis

Start date: 2025-01-08
Primary completion: 2028-11-01
Enrollment: 1680

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.